Opinion: How Should Hyperphosphatemia Be Managed in Dialysis Patients?
- 1 September 2002
- journal article
- review article
- Published by Wiley in Seminars in Dialysis
- Vol. 15 (5) , 315-317
- https://doi.org/10.1046/j.1525-139x.2002.00077_1.x
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patientsKidney International, 2002
- The Calcimimetic Agent AMG 073 Lowers Plasma Parathyroid Hormone Levels in Hemodialysis Patients with Secondary HyperparathyroidismJournal of the American Society of Nephrology, 2002
- Association Between Pulse Pressure and Mortality in Patients Undergoing Maintenance HemodialysisJAMA, 2002
- Impact of years of dialysis therapy on mortality risk and the characteristics of longer term dialysis survivorsAmerican Journal of Kidney Diseases, 2002
- Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteinsKidney International, 2002
- Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal DiseaseHypertension, 2001
- A novel mechanism for skeletal resistance in uremiaKidney International, 2000
- Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing DialysisNew England Journal of Medicine, 2000
- Impact of Aortic Stiffness on Survival in End-Stage Renal DiseaseCirculation, 1999
- Aortic and large artery compliance in end-stage renal failureKidney International, 1990